Enable JavaScript to visit this website.

Rare Diseases > Endocrine Disorders

Select Layout

Pain Assessed Acromegaly Symptom Questionnaire (PASQ)

Click Thumbnail to Review

Pain Assessed Acromegaly Symptom Questionnaire (PASQ)

Description and Context of Use: 
The PASQ measures the symptoms of Acromegaly.
Population age range: 
Adults (18-65)
Number of items: 
Recall Period: 
During the past week including today
Response Scales: 
Numerical rating scale
Administration Mode: 
Self-administered; Paper and pen
Administration Time: 
5 minutes
Schreiber I, Buchfelder M, Droste M, Forssmann K, Mann K, Saller B, Strasburger CJ. Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study. Eur J Endocrinol 2007; 156: 75-82.

Sievers C, Brübach K, Saller B, Schneider HJ, Buchfelder M, Droste M, Mann K, Strasburger C, Stalla GK. Change of symptoms and perceived health in acromegalic patients on pegvisomant therapy: a retrospective cohort study within the German Pegvisomant Observational Study (GPOS). Clin Endocrinol 2010; 73: 89-94.
Original Language: 
English (US)
Select language